Skin Deep Funding for Nia Health

On the path to success: Nia Health founders Oliver Welter and Tobias Seidl – © Nia Health

The Berlin-based health tech company Nia originates from the Charité Berlin and has already developed two award-winning apps which were the first digital medical products of their kind to be approved worldwide, one in the fields of atopic dermatitis (Nia) and one for psoriasis (Sorea). These apps provide anonymized medical information from ordinary patients. This is of huge interest to the company’s network of renowned cooperation partners, consisting of pharmaceutical companies, health insurance companies, and clinics. The growing importance of real world evidence in comparison to clinical trials is reflected in Nia Health’s figures: last year alone, the startup more than doubled its revenue compared to 2021. No wonder Nia Health has now received €3.5M in a seed financing round. The fresh capital will be used for expansion in Europe and into the USA. “The seed funding allows us to massively expand our AI and development capabilities to best address the individual needs of patients with chronic skin conditions,” says co-founder and CTO Oliver Welter.